Seeking Personalized, Holistic Treatment for Ocular and Mental Health, Part II (Written by Sarah Dardarian, I-MED Pharma with Anu Chiarelli, MA, RN) In Part I of this two-part blog post, Anu Chiarelli, a counselling therapist, registered nurse, and dry eye…
How DED Can Impact Mental Health, Part I (Written by Sarah Dardarian, I-MED Pharma with Anu Chiarelli, MA, RN) Dry eye is a disease that affects the ocular surface and tear film. Physical symptoms and the frequency symptoms occur can…
Written by Sarah Dardarian (Sales and Marketing Specialist, I-MED Pharma) As the understanding of dry eye disease (DED) increases, so too does the awareness around effective treatment solutions that help in managing this condition. DED is complicated and so is…
(Written by Sarah Dardarian, Sales and Marketing Specialist, I-MED Pharma) The summer solstice, which happens in June, marks the astronomical start of the summer season in the Northern Hemisphere, meaning longer days, more hours of sunlight, and generally more pleasant…
Written by Sarah Dardarian (Sales and Marketing Specialist, I-MED Pharma) The cosmetics industry is one of the most successful markets in the world. For many people, cosmetics are a part of their everyday life. The use of cosmetics can be…
Dechra Veterinary Products is pleased to announce its exclusive marketing, sales, and distribution agreement with I-MED Pharma, the Canadian leader in dry eye management, for three innovative veterinary hyaluronic acid (HA) ophthalmic products. Dechra has licensed the North American, long-term,…
Written by Sarah Dardarian (Sales & Marketing Specialist, I-MED Pharma) One of the first steps in managing dry eye disease, a multifactorial condition of the ocular surface, is with tear replacement therapy through the use of artificial tears.[1] The aim…
I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud to announce the opening of a European warehouse located in The Netherlands. This strategic location provides excellent connections to the rest of the world to…
I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud to announce a strategic collaboration with Keir Surgical Ltd. to service the ophthalmic needs of Canadian hospitals and Canadian ophthalmologists. As of February 1st, 2021,…
FOR IMMEDIATE RELEASE December 9, 2020, (Montreal, QC, Canada) Article published in December issue of MEDTECH OUTLOOK Magazine medicaltechoutlook.com Taking Eye Care to the Next Level Dry eye disease has plagued the population for years. An estimated 300 million people…
Copyright © 2020 I-MED Pharma inc. All rights reserved.
Privacy | Terms & Conditions
